<?xml version="1.0" encoding="UTF-8"?>
<p>We hypothesise that molecular point-of-care testing for respiratory viruses, in adults presenting to hospital with acute respiratory infection, will reduce antibiotic use, improve detection of influenza and use of neuraminidase inhibitors, improve isolation facility use and be safe.</p>
